Table of Content

Executive Summary
Scope and Definition
Market/Product Definition
Key Questions Answered
Analysis and Forecast Note

1. Global Acute Ischemic Stroke Market: Industry Outlook
1.1 Overview
1.2 Regulatory Landscape of Acute Ischemic Stroke
1.3 Acute Ischemic Stroke Market, Epidemiology Analysis
1.4 Acute Ischemic Stroke Market, Patent Landscape
1.4.1 By Country
1.4.2 By Year
1.5 Acute Ischemic Stroke Market, Clinical Trials Landscape
1.6 Key Trends
1.7 Market Dynamics
1.7.1 Impact Analysis
1.7.2 Market Drivers
1.7.3 Market Restraints
1.7.3 Market Opportunities

2. Global Acute Ischemic Stroke Market, By Therapeutics, $Million, 2023-2035
2.1 Thrombolytic Therapies
2.2 Antiplatelet Therapies
2.3 Antihypertensive Therapies
2.4 Anticoagulants

3. Global Acute Ischemic Stroke Market, by Region, $Million, 2023-2035
3.1 North America
3.1.1 Key Findings in North America
3.1.2 Business Drivers
3.1.3 Business Challenges
3.1.4 Market Sizing and Forecast
3.1.4.1 North America Acute Ischemic Stroke Market, By Country
3.1.4.1.1 U.S.
3.2 Europe
3.2.1 Key Findings in Europe
3.2.2 Business Drivers
3.2.3 Business Challenges
3.2.4 Market Sizing and Forecast
3.2.4.1 Europe Acute Ischemic Stroke Market, By Country
3.2.4.1.1 Germany
3.2.4.1.2 U.K.
3.2.4.1.3 France
3.2.4.1.4 Italy
3.2.4.1.5 Spain
3.3 Asia-Pacific
3.3.1 Key Findings in Asia-Pacific
3.3.2 Business Drivers
3.3.3 Business Challenges
3.3.4 Market Sizing and Forecast
3.3.4.1 Asia-Pacific Acute Ischemic Stroke Market, By Country
3.3.4.1.1 Japan

4. Competitive Landscape and Company Profiles
4.1 Competitive Landscape
4.1.1 New Offerings
4.1.2 Mergers and Acquisitions
4.1.3 Partnerships, Alliances, and Business Expansion
4.1.4 Funding Activities
4.1.5 Regulatory Approvals
4.2 Company Profile
4.2.1 Acticor Biotech
4.2.1.1 Overview
4.2.1.2 Product Portfolio
4.2.1.3 Target Customers
4.2.1.4 Key Professionals
4.2.1.5 Analyst View
4.2.2 Bristol-Myers Squibb
4.2.2.1 Overview
4.2.2.2 Product Portfolio
4.2.2.3 Target Customers
4.2.2.4 Key Professionals
4.2.2.5 Analyst View
4.2.3 Genentech, Inc
4.2.3.1 Overview
4.2.3.2 Product Portfolio
4.2.3.3 Target Customers
4.2.3.4 Key Professionals
4.2.3.5 Analyst View
4.2.4 Athersys|Healios K.K.
4.2.3.1 Overview
4.2.3.2 Product Portfolio
4.2.3.3 Target Customers
4.2.3.4 Key Professionals
4.2.3.5 Analyst View
4.2.5 Biogen Inc
4.2.5.1 Overview
4.2.5.2 Product Portfolio
4.2.5.3 Target Customers
4.2.5.4 Key Professionals
4.2.5.5 Analyst View
4.2.6 AbbVie
4.2.6.1 Overview
4.2.6.2 Product Portfolio
4.2.6.3 Target Customers
4.2.6.4 Key Professionals
4.2.6.5 Analyst View
4.2.7 Revalesio Corporation
4.2.7.1 Overview
4.2.7.2 Product Portfolio
4.2.7.3 Target Customers
4.2.7.4 Key Professionals
4.2.7.5 Analyst View
4.2.8 NoNO Inc.
4.2.8.1 Overview
4.2.8.2 Product Portfolio
4.2.8.3 Target Customers
4.2.8.4 Key Professionals
4.2.8.5 Analyst View
4.2.9 Bayer
4.2.9.1 Overview
4.2.9.2 Product Portfolio
4.2.9.3 Target Customers
4.2.9.4 Key Professionals
4.2.9.5 Analyst View
4.2.10 TrueBinding, Inc
4.2.10.1 Overview
4.2.10.2 Product Portfolio
4.2.10.3 Target Customers
4.2.10.4 Key Professionals
4.2.10.5 Analyst View
4.2.11 Lumosa Therapeutics
4.2.11.1 Overview
4.2.11.2 Product Portfolio
4.2.11.3 Target Customers
4.2.11.4 Key Professionals
4.2.11.5 Analyst View
4.1.12 Janssen Pharmaceutical
4.2.12.1 Overview
4.2.12.2 Product Portfolio
4.2.12.3 Target Customers
4.2.12.4 Key Professionals
4.2.12.5 Analyst View
4.2.13 Silver Creek Pharmaceuticals
4.2.13.1 Overview
4.2.13.2 Product Portfolio
4.2.13.3 Target Customers
4.2.13.4 Key Professionals
4.2.13.5 Analyst View

5. Research Methodology

List of Figures
Figure: Global Acute Ischemic Stroke Market (by Region), $Million, 2024 and 2035
Figure: Global Acute Ischemic Stroke Market Coverage
Figure: Global Acute Ischemic Stroke Market Key Trends, Impact Analysis, 2024-2035

List of Tables
Table: Global Acute Ischemic Stroke Market, Patent Analysis, January 2022-March 2025
Table: Global Acute Ischemic Stroke Market Dynamics, Impact Analysis
Table: Global Acute Ischemic Stroke Market (by Therapeutics), $Million, 2023-2035
Table: Global Acute Ischemic Stroke Market (by Region), $Million, 2023-2035